Compound details
Goniolactone F
| Compound ID | CDAMM01196 |
|---|---|
| Common name | Goniolactone F | IUPAC name | [2-[(5-hydroxy-4-oxo-2-phenyl-2,3-dihydrochromen-7-yl)oxy-phenylmethyl]-5-oxo-3,3a,6,6a-tetrahydro-2H-furo[3,2-b]furan-3-yl] acetate |
| Molecular formula | C30H26O9 |
| Retention time | 0.3 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 531.161 | Theoretical mz | 531.165 |
| Error | 8.43 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.8851 |
| Inchi key | JVHLWFBWUANMQY-JCQZRNDVNA-N |
|---|---|
| Smiles | O=C(OC1C2OC(=O)CC2OC1C(OC=3C=C(O)C4=C(OC(C=5C=CC=CC5)CC4=O)C3)C=6C=CC=CC6)C |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SEA |
| P20151 | KLK2 | Kallikrein 2 | T01908 | SEA |
| P32418 | SLC8A1 | Sodium/calcium exchanger 1 | T07775 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T01908 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P20151 | KLK2 |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |